Medicine
-
FDA Approves Yuhan’s Lazertinib, First Korean-Developed Cancer Drug to Win Approval
South Korea, August 16, 2024 — cyberinktimes.com — Almost four years after South Korean regulators gave it the green light, Lazertinib has…
-
EU Approves New Lymphoma Treatment Odronextamab for Patients
European patients with two forms of lymphoma now have access to a newly approved medication that works through a distinctive biological mechanism.…
-
FDA Approves Eli Lilly Alzheimer’s Drug Kisunla Amid Safety Concerns
July 18, 2024 — infopulsetoday.com — The path to the FDA’s July 15 approval of donanemab was paved with controversy, clinical risk,…
-
FDA Approves Eli Lilly’s Donanemab for Early Symptomatic Alzheimer Disease
On July 15, 2024, the US Food and Drug Administration (FDA) approved donanemab, a monoclonal antibody developed by Eli Lilly and Company,…
-
Northwestern and Brigham Scientists Identify Immune Defect in Lupus and a Possible Way to Reverse It
On July 10, 2024, a joint research team from Northwestern University Feinberg School of Medicine and Harvard Medical School released a study…
-
More Than 320 US Drugs Went Short in 2024, and Many Shortages Lasted Years
The scope of the 2024 drug shortage in the United States extends far beyond a simple inventory problem, now affecting over 300…
-
American Headache Society Endorses CGRP Antagonists for Migraines
On March 11, 2024, the American Headache Society issued a statement that underscores the evolving landscape of migraine treatment, highlighting the emergence…
-
Noland Arbaugh Becomes First Human Recipient Of Neuralink Brain Implant
On January 15, 2024, a significant milestone was achieved in the field of health and technology as Noland Arbaugh, an American man…
-
CRISPR Therapeutics Holds the First Approved CRISPR Therapy, but Its Stock Is Stuck
On December 15, 2023, the biotechnology industry is abuzz with the recent regulatory approval of a groundbreaking treatment by CRISPR Therapeutics AG,…
-
CGRP Drugs and a Wearable Device Give Migraine Patients New Treatment Options
Migraine attacks often strike without warning, bringing intense pain, light sensitivity and nausea. Traditional acute treatments have been limited, and preventive regimens…
-
Fatty Liver Disease Gets a New Name as MASLD Replaces NAFLD in Global Liver Societies’ Consensus
Under a novel nomenclature agreed upon by three prominent global liver organizations, a prevalent liver ailment is set to undergo a significant…
-
Ghanaian Physician Wins Award for Expanding Abortion Access in Africa
On 29 November 2023, Eunice Brookman‑Amissah stepped onto a stage in Stockholm to receive the Right Livelihood Award, a prize often described…
-
FDA Approves Lung Cancer Drug Augtyro for ROS1-Positive Tumors, Trial Shows Responses
The U.S. Food and Drug Administration granted approval on November 15, 2023, for Repotrectinib, marketed as Augtyro, to treat a defined group…
-
City of Hope Drug AOH1996 Moves Through Early Human Trial After Mouse Study Results
An investigational cancer medication called AOH1996 has entered Phase I clinical trials at City of Hope as of August 15, 2023, marking…
-
Fatty liver disease: New classification and understanding as of June 2023
Fatty liver disease (FLD), a condition characterized by the buildup of excess fat in the liver, has been a subject of increasing…
-
Cholera Outbreak Reported in South Africa Since February 2023
South Africa is currently managing a cholera outbreak that first surfaced on 1 February 2023. Since the emergence of these initial cases,…
-
European Commission Approves Niraparib and Abiraterone Tablet for BRCA-Mutated Metastatic Prostate Cancer
European Union, April 19, 2023 — cybernewschronicle.com — Niraparib/abiraterone acetate, a fixed-dose combination anti-cancer medication, has been approved for the treatment of…
-
US Approves New Gene Therapy For Bladder Cancer Treatment
In December 2022 the U.S. Food and Drug Administration granted approval to nadofaragene firadenovec, sold under the brand name Adstiladrin, marking the…
-
FDA Approves Adstiladrin, First Gene Therapy for BCG-Unresponsive Bladder Cancer
United States, December 20, 2022 — cybernewschronicle.com — Nadofaragene firadenovec, a gene therapy marketed under the brand name Adstiladrin, has been approved…
-
FDA Approves Pluvicto for Advanced Prostate Cancer Treatment
A radiopharmaceutical known as Lutetium (177Lu) vipivotide tetraxetan has become available for patients with a specific form of advanced prostate cancer following…
-
FDA Grants Accelerated Approval to Elahere for FRalpha-Positive Platinum-Resistant Ovarian Cancer
The U.S. Food and Drug Administration granted approval on November 15, 2022, to Mirvetuximab soravtansine, a new medication marketed as Elahere, for…
-
FDA Approves Elahere for FRα-Positive Ovarian Cancers
November 17, 2022 — infopulsetoday.com — On November 15, 2022, the FDA approved a drug that works like a guided missile. Mirvetuximab…
-
2022 cholera outbreak in Lebanon
An outbreak of cholera has begun in Lebanon, marking the first incidence of the disease in the country since 1993. The outbreak…
-
FDA Approves Lilly’s Mounjaro, a Once-Weekly Dual-Action Drug for Type 2 Diabetes
Millions of Americans who live with type 2 diabetes now have an additional medication to consider. Tir tirzepatide, cleared by the U.S.…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992